Bioidentical Hormone Therapy

Files, Julia A.; Ko, Marcia G.; Pruthi, Sandhya
July 2011
Mayo Clinic Proceedings;Jul2011, Vol. 86 Issue 7, p673
Academic Journal
The change in hormonal milieu associated with perimenopause and menopause can lead to a variety of symptoms that can affect a woman's quality of life. Postmenopausal hormone therapy (HT) is an effective, well-tolerated treatment for these symptoms. However, combined HT consisting of conjugated equine estrogen and medroxyprogesterone acetate has been associated with an increased number of health risks when compared with conjugated equine estrogen alone or placebo. As a result, some women are turning to alternative hormonal formulations known as compounded bioldentical HT because they perceive them to be a safer alternative. This article defines compounded bioidentical HT and explores the similarities and differences between it and US Food and Drug Administration-approved HT. We will examine the major claims made by proponents of compounded bioidentical HT and recommend strategies for management of patients who request bioidentical HT from physicians.


Related Articles

  • Comparison of Regimens Containing Oral Micronized Progesterone or Medroxyprogesterone Acetate on Quality of Life in Postmenopausal Women: A Cross-Sectional Survey. Fitzpatrick, Lorraine A.; Pace, Cindy; Wiita, Brinda // Journal of Women's Health & Gender-Based Medicine;May2000, Vol. 9 Issue 4, p381 

    A cross-sectional survey was conducted to examine quality of life (QOL) related to physiological, somatic, and vasomotor effects of changing progestogen treatment from medroxyprogesterone acetate (MPA) to micronized progesterone in postmenopausal women. Eligible women (n = 176) were currently...

  • FDA Warns Against Menopausal Hormone Therapy.  // Life Extension;Feb2004, Vol. 10 Issue 2, p27 

    Reports on the nationwide campaign launched by the U.S. Food and Drug Administration on the risks and benefits of menopausal hormone therapy. Inclusion of hormone replacement therapies used by American women; Benefits from the therapy; Serious health concerns associated with the use of these...

  • FDA moves to highlight warnings about HRT. CMAJ // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p753 

    Reports that hormone replacement therapies prescribed in the U.S. must carry warnings that consumers will notice more easily. Introduction of the 'black box' warnings by the U.S. Food and Drug Administration after it reviewed data from the Women's Health Initiative Study; Plans for Health...

  • Hormone Therapy Update. Vanderhaeghe, Lorna // Alive: Canada's Natural Health & Wellness Magazine;Jul2003, Issue 249, p8 

    Focuses on the dangers of hormone replacement therapy (HRT), the combination of synthetic estrogen and progestins. Percentage of Canadian women using HRT who have abandoned the process in 2002; Issue of quality of life outcomes.

  • Effects of hormone therapy on quality of life in postmenopausal women with CAD differed according to menopausal symptoms. Haynes, Joan // ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p105 

    Discusses research being done on the effects of hormone therapy on the health-related quality of life in postmenopausal women with coronary artery disease. Reference to study by M.A. Hlatky and colleagues, published in the February 2002 issue of the 'Journal of American Medical Association';...

  • Taming your raging hormones. Kearns, Brenda // Good Housekeeping;Jul2002, Vol. 235 Issue 1, p85 

    Presents information on how to ease the symptoms of perimenopause. Number of women in the U.S. who are in perimenopause; Effects perimenopause on sex life; Common complaints during perimenopause; Information on hormone replacement therapy.

  • Hormonal recall. Spinney, Laura // New Scientist;09/18/99, Vol. 163 Issue 2204, p12 

    Reports on research being done by scientists at McGill University in Montreal into the effects of estrogen on the memories of women. Findings showing that postmenopausal women who are not taking part in hormone replacement therapy (HRT) have memory lapses; Details of studies performed.

  • Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women. Mattsson, L. A.; Skouby, S.; Rees, M.; Heikkinen, J.; Kudela, M.; Stadnicki-Kolendo, A.; Mattila, L.; Salminen, K.; Vuorela, A.; Mustonen, M. // Menopause International;Sep2007, Vol. 13 Issue 3, p124 

    Objective. Continuous combined hormone replacement therapy (ccHRT) based on estradiol valerate (E2V) and medroxyprogesterone acetate (MPA) is effective for relief of menopausal symptoms three years or more after the menopause. This study was undertaken to examine the efficacy and tolerability of...

  • Practice observed. Gray, Sarah; Newton, Catherine E. // Journal of the British Menopause Society;2003, Vol. 9 Issue 4, p178 

    The article focuses on the results of a study called the Women's Health Initiative study. The study included patients that were chosen from a database of a 12,500 semi-rural practice of Cornwall in England. Premique refers to a preparation of continuous combined hormonal replacement therapy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics